Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study

Bernadette A. Cullen; Katrina Rodriguez; William W. Eaton; Ramin Mojtabai; Tara Von Mach; Michele L. Ybarra

doi:10.1016/j.psychres.2020.113346

Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study

Bernadette A. Cullen, Katrina Rodriguez, William W. Eaton, Ramin Mojtabai, Tara Von Mach, Michele L. Ybarra

Research output: Contribution to journal › Article › peer-review

Abstract

This 6 month randomized control trial investigated whether a novel text-messaging program impacted targeted clinical outcomes in patients with schizophrenia and schizoaffective disorder (SAD). Forty patients were enrolled and completed baseline, 3-month and 6-month assessments. The intervention group received daily symptom check-in text messages, plus, a medication reminder or, inspirational quote text. The control group had treatment as usual. At 6 months the Positive and Negative Syndrome Scale mean positive score was significantly lower and injectable medication compliance was significantly higher in the intervention group. Recovery scores were significantly higher at 3 months. Results suggest that this program may benefit individuals with schizophrenia/SAD who use text messaging. Further investigation in a larger sample appears warranted.

Original language	English (US)
Article number	113346
Journal	Psychiatry research
Volume	292
DOIs	https://doi.org/10.1016/j.psychres.2020.113346
State	Published - Oct 2020

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1016/j.psychres.2020.113346

Cite this

@article{d6f241589e4f4021a4213725f0c2c975,

title = "Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study",

abstract = "This 6 month randomized control trial investigated whether a novel text-messaging program impacted targeted clinical outcomes in patients with schizophrenia and schizoaffective disorder (SAD). Forty patients were enrolled and completed baseline, 3-month and 6-month assessments. The intervention group received daily symptom check-in text messages, plus, a medication reminder or, inspirational quote text. The control group had treatment as usual. At 6 months the Positive and Negative Syndrome Scale mean positive score was significantly lower and injectable medication compliance was significantly higher in the intervention group. Recovery scores were significantly higher at 3 months. Results suggest that this program may benefit individuals with schizophrenia/SAD who use text messaging. Further investigation in a larger sample appears warranted.",

author = "Cullen, {Bernadette A.} and Katrina Rodriguez and Eaton, {William W.} and Ramin Mojtabai and {Von Mach}, Tara and Ybarra, {Michele L.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",

year = "2020",

month = oct,

doi = "10.1016/j.psychres.2020.113346",

language = "English (US)",

volume = "292",

journal = "Psychiatry research",

issn = "0165-1781",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study

AU - Cullen, Bernadette A.

AU - Rodriguez, Katrina

AU - Eaton, William W.

AU - Mojtabai, Ramin

AU - Von Mach, Tara

AU - Ybarra, Michele L.

PY - 2020/10

Y1 - 2020/10

N2 - This 6 month randomized control trial investigated whether a novel text-messaging program impacted targeted clinical outcomes in patients with schizophrenia and schizoaffective disorder (SAD). Forty patients were enrolled and completed baseline, 3-month and 6-month assessments. The intervention group received daily symptom check-in text messages, plus, a medication reminder or, inspirational quote text. The control group had treatment as usual. At 6 months the Positive and Negative Syndrome Scale mean positive score was significantly lower and injectable medication compliance was significantly higher in the intervention group. Recovery scores were significantly higher at 3 months. Results suggest that this program may benefit individuals with schizophrenia/SAD who use text messaging. Further investigation in a larger sample appears warranted.

AB - This 6 month randomized control trial investigated whether a novel text-messaging program impacted targeted clinical outcomes in patients with schizophrenia and schizoaffective disorder (SAD). Forty patients were enrolled and completed baseline, 3-month and 6-month assessments. The intervention group received daily symptom check-in text messages, plus, a medication reminder or, inspirational quote text. The control group had treatment as usual. At 6 months the Positive and Negative Syndrome Scale mean positive score was significantly lower and injectable medication compliance was significantly higher in the intervention group. Recovery scores were significantly higher at 3 months. Results suggest that this program may benefit individuals with schizophrenia/SAD who use text messaging. Further investigation in a larger sample appears warranted.

UR - http://www.scopus.com/inward/record.url?scp=85088971461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088971461&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2020.113346

DO - 10.1016/j.psychres.2020.113346

M3 - Article

C2 - 32750572

AN - SCOPUS:85088971461

SN - 0165-1781

VL - 292

JO - Psychiatry research

JF - Psychiatry research

M1 - 113346

ER -

Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this